格隆汇12月31日丨聚辰股份(688123.SH)公布，为推动公司全球化战略深入实施，面向国际资本市场拓 宽融资渠道，构建多元化资本运作平台，持续增强资本实力和综合竞争力，加速海外业务拓展，完善境 内外协同发展格局，进一步夯实并提升公司在行业中的领先地位，公司计划在境外发行境外上市外资股 （H股），并申请于香港联合交易所有限公司主板上市。 ...

Core Viewpoint - The company, Haitai Biotech (300683.SZ), announced plans to initiate the preparatory work for issuing H-shares and listing on the Hong Kong Stock Exchange by October 22, 2025, aiming to enhance its global strategy and accelerate overseas business development [1] Group 1: Strategic Intent - The company aims to deepen its global strategy and enhance its international brand image through the issuance of H-shares [1] - The move is intended to create a diversified capital operation platform [1] Group 2: Implementation Details - The company plans to discuss specific implementation steps with intermediary institutions, although details are not yet finalized [1] - The issuance and listing of H-shares will require approval from the board of directors, shareholders, and relevant government and regulatory agencies, indicating significant uncertainty in the process [1]